.On the heels of an FDA rejection for its own main rivalrous Novo Nordisk, Eli Lilly is picking up s...
.Only a few months after dosing the first client in a phase 2 trial for recently detected glioblasto...
.Eli Lilly's hunt for being overweight targets has actually led it to the darker genome. The Big Pha...
.Collection Biosciences is proceeding up. The tissue therapy company has added on $325 million in am...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...
.Aelis Farma's chances of protecting a fast, favorable decision on a $one hundred million option rem...
.ProKidney has actually ceased one of a pair of stage 3 trials for its own tissue treatment for rena...
.Vaxcyte unveiled what professionals referred to as "sensational" period 1/2 data for its 31-valent ...
.Recursion has actually stumbled via an early exam of its tech-enabled strategy to medicine discover...
.Contact it a case of good chemistry: Acepodia, a biotech based on Nobel Champion scientific researc...